Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer-Related Condition”

3,726 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 3,726 results

Testing effectiveness (Phase 2)Looking for participantsNCT07002034
What this trial is testing

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

Who this might be right for
Adjustment Disorder
Reunion Neuroscience Inc 100
Not applicableStudy completedNCT02662933
What this trial is testing

Investigating the Relationship Between Physical Function, Comorbidity and Cytogenetic Risk Group in Older Adults With Acute Myelogenous Leukemia (AML)

Who this might be right for
ACUTE MYELOGENOUS LEUKEMIA
Wake Forest University Health Sciences 82
Testing effectiveness (Phase 2)Ended earlyNCT03095248
What this trial is testing

Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors

Who this might be right for
Neurofibromatosis 2Vestibular SchwannomaMeningioma+2 more
Children's Hospital Medical Center, Cincinnati 10
Early research (Phase 1)Study completedNCT00569985
What this trial is testing

Gene Therapy-Treated Stem Cells in Treating Patients Undergoing Stem Cell Transplant for Intermediate-Grade or High-Grade AIDS-Related Lymphoma

Who this might be right for
Lymphoma
City of Hope Medical Center 5
Testing effectiveness (Phase 2)Ended earlyNCT00698685
What this trial is testing

Pentostatin and Alemtuzumab as a Preparative Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation

Who this might be right for
LeukemiaLymphomaHodgkin's Disease+3 more
University of Arizona 14
Not applicableStudy completedNCT06479434
What this trial is testing

Serum Biomarker Levels Improvement in Poly Cystic Ovarian Syndrome: Impact of Metformin Compared to Healthy Controls

Who this might be right for
Polycystic Ovary SyndromeInsulin Resistance
Aga Khan University 110
Not applicableStudy completedNCT06607809
What this trial is testing

Inflammatory Markers (ICC, MCVL) and Nivolumab Response: Predicting Immunotherapy Success in Metastatic RCC

Who this might be right for
Metastatic Renal Cell Carcinoma
Dr. Lutfi Kirdar Kartal Training and Research Hospital 99
Not applicableLooking for participantsNCT06132984
What this trial is testing

Cardiac Magnetic Resonance Monitoring of Immune Checkpoint Inhibitor-related Cardiotoxicity

Who this might be right for
Immune Checkpoint Inhibitors, Cardiotoxicity
West China Second University Hospital 22
Not applicableNot Yet RecruitingNCT07409948
What this trial is testing

Multicomponent Care for Aromatase Inhibitor-Related Musculoskeletal Symptoms

Who this might be right for
Breast NeoplasmsMusculoskeletal PainArthralgia+3 more
Addis Ababa University 88
Not applicableStudy completedNCT04425200
What this trial is testing

Prevalence of HRR-related Genes Mutations and Prognosis in Metastatic Castration Resistant Prostate Cancer (mCRPC) Patients in Real World Setting

Who this might be right for
Prostatic Neoplasms
AstraZeneca 205
Large-scale testing (Phase 3)Not Yet RecruitingNCT06768164
What this trial is testing

Quality of Life After Billroth II or Roux-en-Y for Gastric Cancer

Who this might be right for
Gastric (Cardia, Body) Cancer
Assistance Publique - Hôpitaux de Paris 250
Not applicableUnknownNCT03377829
What this trial is testing

Trial of PLA vs. Surgery for Treating PTMC

Who this might be right for
Thyroid CancerTreatment Related Cancer
WeiWei Zhan 200
Testing effectiveness (Phase 2)Looking for participantsNCT06789601
What this trial is testing

Evaluating Informatics-assisted Immune-related Adverse Event Detection to Improve Registration Onto a Biorepository

Who this might be right for
MalignancyImmune Related Adverse Events
Brigham and Women's Hospital 100
Not applicableStudy completedNCT02605512
What this trial is testing

BreAst Cancer and Cardiotoxicity Induced by RAdioTherapy: the BACCARAT Study

Who this might be right for
Breast CancerCardiac Toxicity
Sophie JACOB 118
Large-scale testing (Phase 3)Ended earlyNCT00092287
What this trial is testing

Comparison of Lanreotide Autogel® and Sandostatin LAR Depot in the Treatment of Clinical Symptoms Associated With Carcinoid Syndrome

Who this might be right for
Malignant Carcinoid Syndrome
Ipsen 4
Not applicableStudy completedNCT06558084
What this trial is testing

Real-World Clinical Outcomes and Toxicity in Metastatic Breast Cancer Patients Treated With First or Second Line CDK 4/6 Inhibitors and Endocrine Therapy

Who this might be right for
Toxicity, DrugProgression, Disease
Ain Shams University 64
Not applicableStudy completedNCT04747249
What this trial is testing

Psychological Care of Oncology Patients With Post-traumatic Stress in the Context of a COVID-19

Who this might be right for
Solid CarcinomaPost Traumatic Stress DisorderCovid19
Centre Francois Baclesse 29
Not applicableLooking for participantsNCT06818149
What this trial is testing

Biomarkers for Clinical Classification and Outcomes of Immune Checkpoint Inhibitor-Related-Related Myocarditis in Lung Cancer

Who this might be right for
Lung CancerMyocarditis Due to Drug
Shanghai Chest Hospital 50
Testing effectiveness (Phase 2)Study completedNCT01412892
What this trial is testing

Use of RAD001 as Monotherapy in the Treatment of Neurofibromatosis 1 Related Internal Plexiform Neurofibromas

Who this might be right for
Neurofibromatosis Type 1Plexiform NeurofibromaNeurofibromatoses
Assistance Publique - Hôpitaux de Paris 30
Not applicableStudy completedNCT03480087
What this trial is testing

Subclinical Cardio-toxicities Evaluation With Strain Rate Echocardiography After Chemotherapy and/or Mediastinal Radiotherapy in Patient With Lymphoma

Who this might be right for
Lymphoma, Non-HodgkinHodgkin LymphomaToxicity, Cardiac
A.O.U. Città della Salute e della Scienza 118
Load More Results